Association of Cigarette Smoking with Albuminuria in the United States: The Third National Health and Nutrition Examination Survey

REFERENCES

• Trosclair A, Husten C, Pederson L, Dhillon I. Cigarette smoking among adults—United States, 2000. MMWR Morb Mortal Wkly Rep. 2002; 51: 642–645
   PubMedGoogle Scholar
• Whelton PK, Randall B, Neaton J, Stamler J, Brancati FL, Klag M. Cigarette smoking and ESRD incidence in men screened for MRFIT. J Am Soc Nephrol. 1995; 6: 408A
   Web of Science ®Google Scholar
• Vupputuri S, Sandler DP. Lifestyle risk factors and chronic kidney disease. Ann Epidemiol. 2003; 13: 712–720
   PubMed Web of Science ®Google Scholar
• Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003; 14: 479–487
   PubMed Web of Science ®Google Scholar
• Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler J, Stamler R, Panarelli W, De Santo NG. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. Arch Intern Med. 1998; 158: 1933–1939
   PubMed Web of Science ®Google Scholar
• Goetz FC, Jacobs DR, Chavers B, Roel J, Yelle M, Sprafka JM. Risk factors for kidney damage in the adult population of Wadena, Minnesota. A prospective study. Am J Epidemiol. 1997; 145: 91–102
   PubMedGoogle Scholar
• Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, de Zeeuw D, De Jong PE. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med. 2000; 133: 585–591
   PubMed Web of Science ®Google Scholar
• Culleton BF, Larson MG, Evans JC, Wilson PW, Barrett BJ, Parfrey PS, Levy D. Prevalence and correlates of elevated serum creatinine levels: the Framingham Heart Study. Arch Intern Med. 1999; 159: 1785–1790
   PubMedGoogle Scholar
• Gambaro G, Verlato F, Budakovic A, Casara D, Saladini G, Del P, Bertaglia G, Masiero M, Checchetto S, Baggio B. Renal impairment in chronic cigarette smokers. J Am Soc Nephrol. 1998; 9: 562–567
   Google Scholar
• Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004; 291: 844–850
   PubMed Web of Science ®Google Scholar
• Ezzati TM, Massey JT, Waksberg J, Chu A, Maurer KR. Sample design: Third National Health and Nutrition Examination Survey. Vital Health. Stat 2. 1992; 113: 21–35
   Google Scholar
• Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–1994. Series 1, No. 32. Programs and Collection Procedures. Department of Health and Human Services Publication No. 94-1308. 1–416, 1994
   Google Scholar
• Gunter EW, McQuillan G. Quality control in planning and operating the laboratory component for the Third National Health and Nutrition Examination Survey. J Nutr. 1990; 120(Suppl. 11)1451–1454
   Google Scholar
• Warram JH, Gearin G, Laffel L, Krolewski AS. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol. 1996; 7: 930–937
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130: 461–470
   PubMed Web of Science ®Google Scholar
• Levey AS, Green T, Kusek JW, Beck GJ, MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000; 11: 155A
   Google Scholar
• Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002; 39: 920–929
   PubMed Web of Science ®Google Scholar
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002; 39: S1–246
   PubMed Web of Science ®Google Scholar
• Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual. Release 7.5, Research Triangle Institute, Research Triangle Park, NC 1997
   Google Scholar
• Ramirez SB, Saleh A, Nandakumar M, Burford S, Lau TWL, Hsu SIH, Owen WF, McClellan W. Smoking is a risk factor for proteinuria as detected by screening in a large cohort of young adult Asians. J Am Soc Nephrol. 1999; 10: 87A
   Google Scholar
• Briganti EM, Branley P, Chadban SJ, Shaw JE, McNeil JJ, Welborn TA, Atkins RC. Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis. 2002; 40: 704–712
   Google Scholar
• Ritz E, Ogata H, Orth SR. Smoking: a factor promoting onset and progression of diabetic nephropathy. Diabetes Metab. 2000; 26(Suppl. 4)54–63
   PubMedGoogle Scholar
• Lafayette RA, Perrone D, Levey AS. Laboratory evaluation of renal function. Diseases of the Kidney6th, RW Schrier, CW Gottschalk. Little, Brown and Company, Boston 1997; 307
   Google Scholar
• Mlacak B, Jaksic Z, Vuletic S. Albuminuria, cardiovascular morbidity and mortality in diabetic and non-diabetic subjects in a rural general practice. Fam Pract. 1999; 16: 580–585
   Google Scholar
• He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive smoking and the risk of coronary heart disease—a meta-analysis of epidemiologic studies. N Engl J Med. 1999; 340: 920–926
   PubMed Web of Science ®Google Scholar
• He J, Whelton PK. Passive cigarette smoking increases risk of coronary heart disease. Eur Heart J. 1999; 20: 1764–1765
   Google Scholar
• Garland C, Barrett-Connor E, Suarez L, Criqui MH, Wingard DL. Effects of passive smoking on ischemic heart disease mortality of nonsmokers. A prospective study. Am J Epidemiol. 1985; 121: 645–650
   PubMed Web of Science ®Google Scholar
• Sandler DP, Comstock GW, Helsing KJ, Shore DL. Deaths from all causes in non-smokers who lived with smokers. Am J Public Health. 1989; 79: 163–167
   PubMed Web of Science ®Google Scholar
• Svendsen KH, Kuller LH, Martin MJ, Ockene JK. Effects of passive smoking in the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1987; 126: 783–795
   PubMed Web of Science ®Google Scholar
• Ciruzzi M, Pramparo P, Esteban O, Rozlosnik J, Tartaglione J, Abecasis B, Cesar J, De RJ, Paterno C, Schargrodsky H. Case-control study of passive smoking at home and risk of acute myocardial infarction. Argentine FRICAS Investigators. Factores de Riesgo Coronario en America del Sur. J Am Coll Cardiol. 1998; 31: 797–803
   Google Scholar
• Nyberg F, Isaksson I, Harris JR, Pershagen G. Misclassification of smoking status and lung cancer risk from environmental tobacco smoke in never-smokers. Epidemiology. 1997; 8: 304–309
   PubMed Web of Science ®Google Scholar
• Nyberg F, Agudo A, Boffetta P, Fortes C, Gonzalez CA, Pershagen G. A European validation study of smoking and environmental tobacco smoke exposure in nonsmoking lung cancer cases and controls. Cancer Causes Control. 1998; 9: 173–182
   PubMed Web of Science ®Google Scholar
• Riggs JE. The “protective” influence of cigarette smoking on Alzheimer's and Parkinson's diseases. Quagmire or opportunity for neuroepidemiology?. Neurol Clin. 1996; 14: 353–358
   Google Scholar
• Keane WF, Kasiske BL, O'Donnell MP. Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis. Am J Nephrol. 1988; 8: 261–271
   PubMed Web of Science ®Google Scholar
• Avram MM. Similarities between glomerular sclerosis and atherosclerosis in human renal biopsy specimens: a role for lipoprotein glomerulopathy. Am J Med. 1989; 87: 39N–41N
   Google Scholar
• Diamond JR. Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int Suppl. 1991; 31: S29–S34
   Google Scholar
• Kamanna VS, Roh DD, Kirschenbaum MA. Atherogenic lipoproteins: mediators of glomerular injury. Am J Nephrol. 1993; 13: 1–5
   Google Scholar
• Grond J, van Goor H, Erkelens DW, Elema JD. Glomerular sclerotic lesions in the rat. Histochemical analysis of their macromolecular and cellular composition. Virchows Arch B Cell Pathol Incl Mol Pathol. 1986; 51: 521–534
   Google Scholar
• McLigeyo SO. Smoking—an emerging risk factor for renal diseases. East Afr Med J. 1998; 75: 171–174
   Google Scholar
• Orth SR. Smoking—a renal risk factor. Nephron. 2000; 86: 12–26
   Google Scholar
• Auerbach O, Hammond EC, Garfinkel L. Thickening of walls of arterioles and small arteries in relation to age and smoking habits. N Engl J Med. 1968; 278: 980–984
   PubMed Web of Science ®Google Scholar
• Black HR, Zeevi GR, Silten RM, Walker S. Effect of heavy cigarette smoking on renal and myocardial arterioles. Nephron. 1983; 34: 173–179
   PubMed Web of Science ®Google Scholar
• Oberai B, Adams CW, High OB. Myocardial and renal arteriolar thickening in cigarette smokers. Atherosclerosis. 1984; 52: 185–190
   PubMed Web of Science ®Google Scholar
• Tracy RE, Malcom GT, Oalmann MC, Newman WP, III, Guzman MA. Nephrosclerosis, glycohemoglobin, cholesterol, and smoking in subjects dying of coronary heart disease. Mod Pathol. 1994; 7: 301–309
   PubMedGoogle Scholar
• Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M. Health effects of cadmium exposure—a review of the literature and a risk estimate. Scand J Work Environ Health. 1998; 24(Suppl. 1)1–51
   PubMedGoogle Scholar
• Satarug S, Moore MR. Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ Health Perspect. 2004; 112: 1099–1103
   PubMed Web of Science ®Google Scholar